Lion TCR receives US$ 20 million to fund its personalized T cell therapy clinical trials against Liver cancer

May 28, 2018 | By - | Filed in: Press Releases.

SINGAPORE, May 27, 2018 /PRNewswire/ — Lion TCR Pte Ltd, a clinical stage biotech pioneering T cell therapy against viral- related cancer, announced today they have raised US$ 20 million in its Series A financing round. The money raised is led primarily by undisclosed existing investors…

To post and circulate your own press release on FIR and the eTN Network  please click here 


Comments are closed here.